Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Cardiology Reviews
  4. Fast Track Articles
  5. Fast Track Article
image of Atrial Fibrillation Ablation in Heart Failure and Preserved Ejection Fraction: An Observational Study of Risk Factors for Heart Failure Hospitalization

Abstract

Introduction

Long-term heart failure hospitalization (HFH) after radiofrequency catheter ablation (RFCA) in atrial fibrillation (AF) patients with heart failure and preserved ejection fraction (HFpEF) and its risk factors remain to be investigated.

Methods

AF patients with HFpEF who underwent RFCA from January, 2014 to December, 2018 from three centers were retrospectively included. Patients were assigned to the training and testing cohorts, respectively. In the training cohort, logistic regression analyses were performed to discriminate those with and without HFH. A scoring system was developed accordingly and validated.

Results

A total of 417 AF patients with HFpEF receiving RFCA were enrolled. About 35 patients (8.4%) had HFH for 6 years. In the training cohort, the use of diuretics, atrial tachycardia (AT)/AF recurrence, prior HFH, and female sex were independent predictors of HFH in the multivariable analysis. A DAPF score (ranging from 0 to 9.0) was developed. The area under the receiver operating characteristic curve (AUC) of the DAPF score was 0.880 (95% CI, 0.830-0.929). A DAPF score ≥3.5 could predict HFH with a sensitivity of 81.8% and a specificity of 74.6%. The performance in the testing cohort remained robust (AUC, 0.858; 95% CI, 0.749-0.967).

Conclusion

HFH in patients with AF and HFpEF after RFCA is not rare. The DAPF score could predict the risk of HFH in AF patients with HFpEF after RFCA and guide our treatment strategy.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ccr/10.2174/011573403X348844241129111639
2024-12-09
2025-01-09

  • From This Site

    /content/journals/ccr/10.2174/011573403X348844241129111639
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Santhanakrishnan R. Wang N. Larson M.G. Magnani J.W. McManus D.D. Lubitz S.A. Ellinor P.T. Cheng S. Vasan R.S. Lee D.S. Wang T.J. Levy D. Benjamin E.J. Ho J.E. Atrial fibrillation begets heart failure and vice versa. Circulation 2016 133 5 484 492 10.1161/CIRCULATIONAHA.115.018614 26746177
    [Google Scholar]
  2. Kosmala W. Heart failure with preserved ejection fraction and atrial fibrillation. J. Am. Coll. Cardiol. 2020 76 9 1065 1067 10.1016/j.jacc.2020.07.024 32854841
    [Google Scholar]
  3. Sartipy U. Dahlström U. Fu M. Lund L.H. Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction. JACC Heart Fail. 2017 5 8 565 574 10.1016/j.jchf.2017.05.001 28711451
    [Google Scholar]
  4. Fauchier L. Bisson A. Bodin A. Heart failure with preserved ejection fraction and atrial fibrillation: Recent advances and open questions. BMC Med. 2023 21 1 54 10.1186/s12916‑023‑02764‑3 36782248
    [Google Scholar]
  5. McDonagh T.A. Metra M. Adamo M. Gardner R.S. Baumbach A. Böhm M. Burri H. Butler J. Čelutkienė J. Chioncel O. Cleland J.G.F. Coats A.J.S. Crespo-Leiro M.G. Farmakis D. Gilard M. Heymans S. Hoes A.W. Jaarsma T. Jankowska E.A. Lainscak M. Lam C.S.P. Lyon A.R. McMurray J.J.V. Mebazaa A. Mindham R. Muneretto C. Francesco Piepoli M. Price S. Rosano G.M.C. Ruschitzka F. Kathrine Skibelund A. de Boer R.A. Christian Schulze P. Abdelhamid M. Aboyans V. Adamopoulos S. Anker S.D. Arbelo E. Asteggiano R. Bauersachs J. Bayes-Genis A. Borger M.A. Budts W. Cikes M. Damman K. Delgado V. Dendale P. Dilaveris P. Drexel H. Ezekowitz J. Falk V. Fauchier L. Filippatos G. Fraser A. Frey N. Gale C.P. Gustafsson F. Harris J. Iung B. Janssens S. Jessup M. Konradi A. Kotecha D. Lambrinou E. Lancellotti P. Landmesser U. Leclercq C. Lewis B.S. Leyva F. Linhart A. Løchen M-L. Lund L.H. Mancini D. Masip J. Milicic D. Mueller C. Nef H. Nielsen J-C. Neubeck L. Noutsias M. Petersen S.E. Sonia Petronio A. Ponikowski P. Prescott E. Rakisheva A. Richter D.J. Schlyakhto E. Seferovic P. Senni M. Sitges M. Sousa-Uva M. Tocchetti C.G. Touyz R.M. Tschoepe C. Waltenberger J. Adamo M. Baumbach A. Böhm M. Burri H. Čelutkienė J. Chioncel O. Cleland J.G.F. Coats A.J.S. Crespo-Leiro M.G. Farmakis D. Gardner R.S. Gilard M. Heymans S. Hoes A.W. Jaarsma T. Jankowska E.A. Lainscak M. Lam C.S.P. Lyon A.R. McMurray J.J.V. Mebazaa A. Mindham R. Muneretto C. Piepoli M.F. Price S. Rosano G.M.C. Ruschitzka F. Skibelund A.K. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 2021 42 36 3599 3726 10.1093/eurheartj/ehab368 34447992
    [Google Scholar]
  6. Son M.K. Park J.J. Lim N.K. Kim W.H. Choi D.J. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction. Heart 2020 106 15 1160 1168 10.1136/heartjnl‑2019‑316219 32341140
    [Google Scholar]
  7. Packer D.L. Piccini J.P. Monahan K.H. Al-Khalidi H.R. Silverstein A.P. Noseworthy P.A. Poole J.E. Bahnson T.D. Lee K.L. Mark D.B. Ablation versus drug therapy for atrial fibrillation in heart failure. Circulation 2021 143 14 1377 1390 10.1161/CIRCULATIONAHA.120.050991 33554614
    [Google Scholar]
  8. Marrouche N.F. Brachmann J. Andresen D. Siebels J. Boersma L. Jordaens L. Merkely B. Pokushalov E. Sanders P. Proff J. Schunkert H. Christ H. Vogt J. Bänsch D. Catheter ablation for atrial fibrillation with heart failure. N. Engl. J. Med. 2018 378 5 417 427 10.1056/NEJMoa1707855 29385358
    [Google Scholar]
  9. Fujimoto H. Doi N. Okayama S. Naito M. Kobori A. Kaitani K. Inoue K. Kurotobi T. Morishima I. Yamaji H. Matsui Y. Nakazawa Y. Kusano K. Hirai K. Nakai T. Suzuki M. Yano H. Sakai S. Kimura T. Shizuta S. Saito Y. Long-term prognosis of patients undergoing radiofrequency catheter ablation for atrial fibrillation: Comparison between heart failure subtypes based on left ventricular ejection fraction. Europace 2022 24 4 576 586 10.1093/europace/euab201 34463733
    [Google Scholar]
  10. Rillig A. Magnussen C. Ozga A.K. Suling A. Brandes A. Breithardt G. Camm A.J. Crijns H.J.G.M. Eckardt L. Elvan A. Goette A. Gulizia M. Haegeli L. Heidbuchel H. Kuck K.H. Ng A. Szumowski L. van Gelder I. Wegscheider K. Kirchhof P. Early rhythm control therapy in patients with atrial fibrillation and heart failure. Circulation 2021 144 11 845 858 10.1161/CIRCULATIONAHA.121.056323 34328366
    [Google Scholar]
  11. Parkash R. Wells G.A. Rouleau J. Talajic M. Essebag V. Skanes A. Wilton S.B. Verma A. Healey J.S. Sterns L. Bennett M. Roux J.F. Rivard L. Leong-Sit P. Jensen-Urstad M. Jolly U. Philippon F. Sapp J.L. Tang A.S.L. MacDonald P. Bennett M. Chakrabarti S. Yeung-Lai-Wah J. Ignaszewski A. Tung S. Virani S. Deyell M. Krahn A. Andrade J. Straatman L. Toma M. Wong G. Wei M. Greiss I. Raymond J-M. Coutu B. Costi P. Mansour F. Saint-Phard W. Denis I. Fleury J. Roux J-F. Ayala-Paredes F. Badra-Verdu M. Dussault C. Vachon N. Dagenais V. Lamoureux C. Healey J. Connolly S. Ribas C.S. Divakaramenon S. Wong J. Amit G. Meyer W. Nault I. Champagne J. Sarrazin J-F. O’Hara G. Philippon F. Blier L. Plourde B. Steinburg C. Roy K. Banville P. Ottinger B. Boucher M-E. Sanchez M. Rivard L. Dubuc M. Guerra P. Dyrda K. Khairy P. Macle L. Mondesert B. Roy D. Talajic M. Thibault B. Tadros R. Roy V. Redfearn D. Abdollah H. Baranchuk A. Michael K. Simpson C. Hammond S. Wilton S.B. Clarke B. Morillo C. Kuriachan V. Veenhuyzen G. Quinn R. Exner D. Howlett J. McKeage J. Leong-Sit P. Gula L. Skanes A. Manlucu J. Tang A. Klein G. Wall S. El-Sakka Y. Essebag V. Hadjis T. Bernier M. Joza J. Roux J-F. Omelchenko A. Nascimento T. Rafti F. DiStefano I. Parkash R. Sapp J. Gray C. Gardner M. Abdel-Wahab A. MacIntyre C.J. Rajda M. O’Regan P. Levins-Lamont M.L. Lockwood E. Hruczkowski T. Valtuille L. Chan M. Halenar J. McLean S. Verma A. Khaykin Y. Nyman L. Wulffhart Z. Pantano A. Tsang B. Patterson S. Nath A. Nyman L. Jolly U. Rinne C. Janzen I. Crystal E. Lashevsky I. Singh S. Tiong I. Syeda A. Tremblay A. Ha A.C.T. Chauhan V. Hill A. Nery P. Birnie D. Redpath C. Green M. Nair G. Lemery R. Sadek M. MacDonald K. Sterns L. Novak P. Leather R. Swiggum E. Sikkel M. Lane C. Rakochey T. Patterson C. Luz Leiria T.L. Glotz de Lima G. Sant’Anna R. Dutz E. Klein Weber C. Peixoto Deiro A. Hoscheidt L.M. Jensen-Urstad M. Linde C. Saluveer O. Carnlof C. Yu C-C. Chiu F-C. Lin J-L. Huang C-Y. Wells G.A. Theoret-Patrick P. Ryan J. Tran M-L. Chen L. Singh S. Tang A. Wells G. Talajic M. Rouleau J. Parkash R. Tang A. Wells G. Talajic M. Rouleau J. Parkash R. Verma A. Essebag V. Birnie D. Healey J. Macle L. Newton G. Coyle D. Skanes A. Wilton S.B. Wyse G. Cassidy D. Thabane L. Verma A. Morillo C. Healey J. Newton G. Sapp J. Philippon F. Gula L. Swiggum E. Mielniczuk L. Nery P. Nault I. Wilton S.B. Ha A. Rivard L. Luz Leiria T.I.L. Tung S. Tzemos N. Mathew A. Thain D. Wall S. Parkash R. MacDonald A. Shields M. Randomized ablation-based rhythm-control versus rate-control trial in patients with heart failure and atrial fibrillation: results from the RAFT-AF trial. Circulation 2022 145 23 1693 1704 10.1161/CIRCULATIONAHA.121.057095 35313733
    [Google Scholar]
  12. Patel R.B. Vaduganathan M. Shah S.J. Butler J. Atrial fibrillation in heart failure with preserved ejection fraction: Insights into mechanisms and therapeutics. Pharmacol. Ther. 2017 176 32 39 10.1016/j.pharmthera.2016.10.019 27773787
    [Google Scholar]
  13. Qin D. Heist E.K. Atrial fibrillation ablation in congestive heart failure with preserved ejection fraction: Tackling the vicious twins. J. Cardiovasc. Electrophysiol. 2020 31 3 689 691 10.1111/jce.14370 32022340
    [Google Scholar]
  14. Johner N. Namdar M. Shah D.C. Safety, efficacy and prognostic benefit of atrial fibrillation ablation in heart failure with preserved ejection fraction. Arrhythm. Electrophysiol. Rev. 2022 11 e18 10.15420/aer.2022.10 36304203
    [Google Scholar]
  15. Mahalleh M. Soleimani H. Pazoki M. Maleki S. Dastjerdi P. Ebrahimi P. Zafarmandi S. Khamene S.S. Khawajah I.M. Tabassum S. Bhardwaj R. Mattumpuram J. Kaplan A. Vaseghi M. Seilani P. Bozorgi A. Hosseini K. Tzeis S. Heart failure with preserved ejection fraction and atrial fibrillation: catheter ablation vs. standard medical therapy — a systematic review and meta-analysis. Heart Fail. Rev. 2024 10.1007/s10741‑024‑10437‑3 39278992
    [Google Scholar]
  16. Xie Z. Qi B. Wang Z. Li F. Chen C. Li C. Yuan S. Yao S. Zhou J. Ge J. Ablation for atrial fibrillation improves the outcomes in patients with heart failure with preserved ejection fraction. Europace 2023 26 1 euad363 10.1093/europace/euad363 38099508
    [Google Scholar]
  17. Androulakis E. Sohrabi C. Briasoulis A. Bakogiannis C. Saberwal B. Siasos G. Tousoulis D. Ahsan S. Papageorgiou N. Catheter ablation for atrial fibrillation in patients with heart failure with preserved ejection fraction: A systematic review and meta-analysis. J. Clin. Med. 2022 11 2 288 10.3390/jcm11020288 35053984
    [Google Scholar]
  18. Fukui A. Tanino T. Yamaguchi T. Hirota K. Saito S. Okada N. Akioka H. Shinohara T. Yufu K. Takahashi N. Catheter ablation of atrial fibrillation reduces heart failure rehospitalization in patients with heart failure with preserved ejection fraction. J. Cardiovasc. Electrophysiol. 2020 31 3 682 688 10.1111/jce.14369 31985099
    [Google Scholar]
  19. Chieng D. Sugumar H. Segan L. Tan C. Vizi D. Nanayakkara S. Al-Kaisey A. Hawson J. Prabhu S. Voskoboinik A. Finch S. Morton J.B. Lee G. Mariani J. La Gerche A. Taylor A.J. Howden E. Kistler P.M. Kalman J.M. Kaye D.M. Ling L.H. Atrial fibrillation ablation for heart failure with preserved ejection fraction. JACC Heart Fail. 2023 11 6 646 658 10.1016/j.jchf.2023.01.008 36868916
    [Google Scholar]
  20. Brachmann J. Sohns C. Andresen D. Siebels J. Sehner S. Boersma L. Merkely B. Pokushalov E. Sanders P. Schunkert H. Bänsch D. Dagher L. Zhao Y. Mahnkopf C. Wegscheider K. Marrouche N.F. atrial fibrillation burden and clinical outcomes in heart failure. JACC Clin. Electrophysiol. 2021 7 5 594 603 10.1016/j.jacep.2020.11.021 33640355
    [Google Scholar]
  21. Oraii A. McIntyre W.F. Parkash R. Kowalik K. Razeghi G. Benz A.P. Belley-Côté E.P. Conen D. Connolly S.J. Tang A.S.L. Healey J.S. Wong J.A. Atrial fibrillation ablation in heart failure with reduced vs preserved ejection fraction. JAMA Cardiol. 2024 9 6 545 555 10.1001/jamacardio.2024.0675 38656292
    [Google Scholar]
  22. Kotecha D. Lam C.S.P. Van Veldhuisen D.J. Van Gelder I.C. Voors A.A. Rienstra M. Heart failure with preserved ejection fraction and atrial fibrillation. J. Am. Coll. Cardiol. 2016 68 20 2217 2228 10.1016/j.jacc.2016.08.048 27855811
    [Google Scholar]
  23. Patton K.K. Yancy C.W. Atrial fibrillation ablation in heart failure—more data are needed. JAMA Cardiol. 2024 9 6 555 10.1001/jamacardio.2024.0684 38656536
    [Google Scholar]
  24. Greet B. Schurmann P. Deswal A. In AF and HF, catheter ablation vs medical therapy reduced mortality and hospitalization for worsening HF. Ann. Intern. Med. 2018 168 10 JC55 10.7326/ACPJC‑2018‑168‑10‑055 29800431
    [Google Scholar]
  25. Heidenreich P.A. Bozkurt B. Aguilar D. Allen L.A. Byun J.J. Colvin M.M. Deswal A. Drazner M.H. Dunlay S.M. Evers L.R. Fang J.C. Fedson S.E. Fonarow G.C. Hayek S.S. Hernandez A.F. Khazanie P. Kittleson M.M. Lee C.S. Link M.S. Milano C.A. Nnacheta L.C. Sandhu A.T. Stevenson L.W. Vardeny O. Vest A.R. Yancy C.W. 2022 AHA/ACC/HFSA guideline for the management of heart failure: A report of the american college of cardiology/american heart association joint committee on clinical practice guidelines. Circulation 2022 145 18 e895 e1032 10.1161/CIR.0000000000001063 35363499
    [Google Scholar]
  26. Bozkurt B. Coats A.J. Tsutsui H. Universal definition and classification of heart failure: a report of the heart failure society of america, heart failure association of the european society of cardiology, japanese heart failure society and writing committee of the universal definition of heart failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association. Eur. J. Heart Fail. 2021 23 3 352 380 10.1002/ejhf.2115
    [Google Scholar]
  27. Campbell P. Rutten F.H. Lee M.M.Y. Hawkins N.M. Petrie M.C. Heart failure with preserved ejection fraction: Everything the clinician needs to know. Lancet 2024 403 10431 1083 1092 10.1016/S0140‑6736(23)02756‑3 38367642
    [Google Scholar]
  28. Pieske B. Tschöpe C. de Boer R.A. Fraser A.G. Anker S.D. Donal E. Edelmann F. Fu M. Guazzi M. Lam C.S.P. Lancellotti P. Melenovsky V. Morris D.A. Nagel E. Pieske-Kraigher E. Ponikowski P. Solomon S.D. Vasan R.S. Rutten F.H. Voors A.A. Ruschitzka F. Paulus W.J. Seferovic P. Filippatos G. How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: A consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur. Heart J. 2019 40 40 3297 3317 10.1093/eurheartj/ehz641 31504452
    [Google Scholar]
  29. Tangri N. Peach E.J. Franzén S. Barone S. Kushner P.R. Patient management and clinical outcomes associated with a recorded diagnosis of stage 3 chronic kidney disease: The REVEAL-CKD study. Adv. Ther. 2023 40 6 2869 2885 10.1007/s12325‑023‑02482‑5 37133647
    [Google Scholar]
  30. Gu Z. Jiao J. Shen Y. Ding X. Zhu C. Li M. Chen H. Ju W. Gu K. Yang G. Liu H. Kojodjojo P. Chen M. A simple score to predict new-onset atrial fibrillation after ablation of typical atrial flutter. Can. J. Cardiol. 2024 40 9 1580 1589 10.1016/j.cjca.2024.02.006 38369258
    [Google Scholar]
  31. Chen X. Liu H. Zhang Y. Wang C. Xu D. Yang B. Ju W. Zhang F. Chen H. Cao K. Chen M. Atrial electromechanical delay assessment in early phase after catheter ablation for patients with atrial fibrillation. Pacing Clin. Electrophysiol. 2019 42 3 327 332 10.1111/pace.13602 30632635
    [Google Scholar]
  32. Tzeis S. Gerstenfeld E.P. Kalman J. Saad E.B. Sepehri Shamloo A. Andrade J.G. Barbhaiya C.R. Baykaner T. Boveda S. Calkins H. Chan N.Y. Chen M. Chen S.A. Dagres N. Damiano R.J. De Potter T. Deisenhofer I. Derval N. Di Biase L. Duytschaever M. Dyrda K. Hindricks G. Hocini M. Kim Y.H. la Meir M. Merino J.L. Michaud G.F. Natale A. Nault I. Nava S. Nitta T. O’Neill M. Pak H.N. Piccini J.P. Pürerfellner H. Reichlin T. Saenz L.C. Sanders P. Schilling R. Schmidt B. Supple G.E. Thomas K.L. Tondo C. Verma A. Wan E.Y. Steven D. Agbayani M.J. Jared Bunch T. Chugh A. Díaz J.C. Freeman J.V. Hardy C.A. Heidbuchel H. Johar S. Linz D. Maesen B. Noseworthy P.A. Oh S. Porta-Sanchez A. Potpara T. Rodriguez-Diez G. Sacher F. Suwalski P. Trines S.A. 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace 2024 26 4 euae043 10.1093/europace/euae043 38587017
    [Google Scholar]
  33. Yang G. Zheng L. Jiang C. Fan J. Liu X. Zhan X. Li J. Wang L. Yang H. Zhu W. Du H. Ma G. Ma W. Kojodjojo P. Chen M. Circumferential pulmonary vein isolation plus low-voltage area modification in persistent atrial fibrillation. JACC Clin. Electrophysiol. 2022 8 7 882 891 10.1016/j.jacep.2022.03.012 35863814
    [Google Scholar]
  34. Chen H. Li C. Han B. Xiao F. Yi F. Wei Y. Jiang C. Zou C. Shi L. Ma W. Wang W. Wang Y. Du H. Chen L. Chen M. Chen M. Han B. Jiang C. Ju W. Yang G. Wang Z. Yang H. Wang J. Fang P. Wang Z. Zhang C. Li F. Chen X. Huang J. Tai C. Hao J. Chen Y. Wu S. Jiang T. Zhang Y. Hu M. Li J. Hu M. Li S. Li W. Li X. Yang L. Zhai L. Wang X. Liu Q. Yu L. Jiang R. Chen S. Fan S. Zhang F. Li J. Li X. Liu Y. Ma G. Li M. Shen Y. Cui C. Liu H. Cai C. Jiang X. Wu N. Sun X. Yan Q. Wang K. Wu W. Zhang F. Yao X. Yu H. Wang X. Lu Z. Wang L. Cao J. Circumferential pulmonary vein isolation with vs without additional low-voltage-area ablation in older patients with paroxysmal atrial fibrillation. JAMA Cardiol. 2023 8 8 765 772 10.1001/jamacardio.2023.1749 37378966
    [Google Scholar]
  35. Tzeis S. Gerstenfeld E.P. Kalman J. Saad E.B. Shamloo A.S. Andrade J.G. Barbhaiya C.R. Baykaner T. Boveda S. Calkins H. Chan N.Y. Chen M. Chen S.A. Dagres N. Damiano R.J. De Potter T. Deisenhofer I. Derval N. Di Biase L. Duytschaever M. Dyrda K. Hindricks G. Hocini M. Kim Y.H. la Meir M. Merino J.L. Michaud G.F. Natale A. Nault I. Nava S. Nitta T. O’Neill M. Pak H.N. Piccini J.P. Pürerfellner H. Reichlin T. Saenz L.C. Sanders P. Schilling R. Schmidt B. Supple G.E. Thomas K.L. Tondo C. Verma A. Wan E.Y. 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2024 21 9 e31 e149 10.1016/j.hrthm.2024.03.017 38597857
    [Google Scholar]
  36. Chioncel O. Mebazaa A. Harjola V.P. Coats A.J. Piepoli M.F. Crespo-Leiro M.G. Laroche C. Seferovic P.M. Anker S.D. Ferrari R. Ruschitzka F. Lopez-Fernandez S. Miani D. Filippatos G. Maggioni A.P. Clinical phenotypes and outcome of patients hospitalized for acute heart failure: The ESC Heart Failure Long‐Term Registry. Eur. J. Heart Fail. 2017 19 10 1242 1254 10.1002/ejhf.890 28463462
    [Google Scholar]
  37. Adams K.F. Jr Fonarow G.C. Emerman C.L. LeJemtel T.H. Costanzo M.R. Abraham W.T. Berkowitz R.L. Galvao M. Horton D.P. Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am. Heart J. 2005 149 2 209 216 10.1016/j.ahj.2004.08.005 15846257
    [Google Scholar]
  38. Zhang Y. Zhang J. Butler J. Yang X. Xie P. Guo D. Wei T. Yu J. Wu Z. Gao Y. Han X. Zhang X. Wen S. Anker S.D. Filippatos G. Fonarow G.C. Gan T. Zhang R. Contemporary epidemiology, management, and outcomes of patients hospitalized for heart failure in china: Results from the china heart failure (China-HF) registry. J. Card. Fail. 2017 23 12 868 875 10.1016/j.cardfail.2017.09.014 29029965
    [Google Scholar]
  39. Peng X. Wang S. Ju W. Yang G. Gu K. Liu H. Li M. Chen H. Wang J. Chen M. Right atrial tachycardia after atrial fibrillation ablation: Prevalence, clinical characteristics, electrophysiological mechanisms, and long-term outcomes. J. Interv. Card. Electrophysiol. 2023 66 7 1641 1650 10.1007/s10840‑023‑01482‑3 36692686
    [Google Scholar]
  40. Poole J.E. Bahnson T.D. Monahan K.H. Johnson G. Rostami H. Silverstein A.P. Al-Khalidi H.R. Rosenberg Y. Mark D.B. Lee K.L. Packer D.L. Poole J.E. Akoum N. Aoukar P. Birgersdotter-Green U. Blatt J. Cha Y.M. Chung M. Gleva M. Glotzer T. Henrickson C. Kron J. Kuriachan V. Mulpuru S. Noseworthy P. Patton K. Prutkin J. Ranjan R. Rho R. Russo A. Stecker E. Tzou W. Serdoz L.V. Wilson M. Recurrence of atrial fibrillation after catheter ablation or antiarrhythmic drug therapy in the CABANA trial. J. Am. Coll. Cardiol. 2020 75 25 3105 3118 10.1016/j.jacc.2020.04.065 32586583
    [Google Scholar]
  41. Szilágyi J. Walters T.E. Marcus G.M. Vedantham V. Moss J.D. Badhwar N. Lee B. Lee R. Tseng Z.H. Gerstenfeld E.P. Surface ECG and intracardiac spectral measures predict atrial fibrillation recurrence after catheter ablation. J. Cardiovasc. Electrophysiol. 2018 29 10 1371 1378 10.1111/jce.13699 30016007
    [Google Scholar]
  42. Taniguchi N. Miyasaka Y. Suwa Y. Harada S. Nakai E. Shiojima I. Heart failure in atrial fibrillation ― An update on clinical and echocardiographic implications ―. Circ. J. 2020 84 8 1212 1217 10.1253/circj.CJ‑20‑0258 32641592
    [Google Scholar]
  43. Pagliaro B.R. Mincione G. Taormina A. Ceriotti C. Poggio L. Cannata F. Del Monaco G. Gitto M. Battaglia V. Pinna G. Galimberti P. Loiacono F. Pellegrino M. Panico C. Bragato R. Stefanini G. Condorelli G. Pini D. Frontera A. Atrial arrhythmias and heart failure: A “modern view” of an old paradox. Pacing Clin. Electrophysiol. 2023 46 5 395 408 10.1111/pace.14697 36949598
    [Google Scholar]
  44. Verhaert D.V.M. Brunner-La Rocca H.P. van Veldhuisen D.J. Vernooy K. The bidirectional interaction between atrial fibrillation and heart failure: consequences for the management of both diseases. Europace 2021 23 23 Suppl. 2 ii40 ii45 10.1093/europace/euaa368 33837758
    [Google Scholar]
  45. Hohendanner F. Heinzel F.R. Blaschke F. Pieske B.M. Haverkamp W. Boldt H.L. Parwani A.S. Pathophysiological and therapeutic implications in patients with atrial fibrillation and heart failure. Heart Fail. Rev. 2018 23 1 27 36 10.1007/s10741‑017‑9657‑9 29038991
    [Google Scholar]
  46. Reddy Y.N.V. Obokata M. Verbrugge F.H. Lin G. Borlaug B.A. Atrial dysfunction in patients with heart failure with preserved ejection fraction and atrial fibrillation. J. Am. Coll. Cardiol. 2020 76 9 1051 1064 10.1016/j.jacc.2020.07.009 32854840
    [Google Scholar]
  47. Ben-Arzi A. Hazanov E. Ghanim D. Rozen G. Marai I. Grosman-Rimon L. Kachel E. Amir O. Carasso S. Left atrial minimal volume: Association with diastolic dysfunction and heart failure in patients in sinus rhythm or atrial fibrillation with preserved ejection fraction. BMC Med. Imaging 2021 21 1 76 10.1186/s12880‑021‑00606‑3 33957873
    [Google Scholar]
  48. Beladan C.C. Gual-Capllonch F. Popescu A.C. Popescu B.A. Diagnosing diastolic dysfunction and heart failure with preserved ejection fraction in patients with atrial fibrillation: A clinical challenge. Eur. Heart J. Cardiovasc. Imaging 2024 25 11 1546 1553 10.1093/ehjci/jeae160 38940621
    [Google Scholar]
  49. Redfield M.M. Borlaug B.A. Heart failure with preserved ejection fraction. JAMA 2023 329 10 827 838 10.1001/jama.2023.2020 36917048
    [Google Scholar]
  50. Silva M.R. Sampaio F. Braga J. Ribeiro J. Fontes-Carvalho R. Left atrial strain evaluation to assess left ventricle diastolic dysfunction and heart failure with preserved ejection fraction: A guide to clinical practice. Int. J. Cardiovasc. Imaging 2023 39 6 1083 1096 10.1007/s10554‑023‑02816‑y 36826616
    [Google Scholar]
  51. Zylla M.M. Leiner J. Rahm A.K. Hoffmann T. Lugenbiel P. Schweizer P. Scholz E. Mereles D. Kronsteiner D. Kieser M. Katus H.A. Frey N. Thomas D. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction. Circ. Heart Fail. 2022 15 9 e009281 10.1161/CIRCHEARTFAILURE.121.009281 36126143
    [Google Scholar]
  52. Boorsma E.M. ter Maaten J.M. Damman K. Dinh W. Gustafsson F. Goldsmith S. Burkhoff D. Zannad F. Udelson J.E. Voors A.A. Congestion in heart failure: A contemporary look at physiology, diagnosis and treatment. Nat. Rev. Cardiol. 2020 17 10 641 655 10.1038/s41569‑020‑0379‑7 32415147
    [Google Scholar]
  53. Tanaka N. Inoue K. Kobori A. Kaitani K. Morimoto T. Kurotobi T. Morishima I. Yamaji H. Matsui Y. Nakazawa Y. Kusano K. Tanaka K. Hirao Y. Okada M. Koyama Y. Okamura A. Iwakura K. Fujii K. Kimura T. Shizuta S. Atrial fibrillation ablation outcomes and heart failure (from the kansai plus atrial fibrillation registry). Am. J. Cardiol. 2023 189 108 118 10.1016/j.amjcard.2022.11.038 36525835
    [Google Scholar]
  54. Calvert P. Farinha J.M. Gupta D. Kahn M. Proietti R. Lip G.Y.H. A comparison of medical therapy and ablation for atrial fibrillation in patients with heart failure. Expert Rev. Cardiovasc. Ther. 2022 20 3 169 183 10.1080/14779072.2022.2050695 35255780
    [Google Scholar]
  55. Kataoka N. Imamura T. Koi T. Uchida K. Kinugawa K. Adverse events requiring hospitalization following catheter ablation for atrial fibrillation in heart failure with versus without systolic dysfunction. J. Cardiovasc. Dev. Dis. 2024 11 2 35 10.3390/jcdd11020035 38392249
    [Google Scholar]
  56. Johnson L.S.B. Oldgren J. Barrett T.W. McNaughton C.D. Wong J.A. McIntyre W.F. Freeman C.L. Murphy L. Engström G. Ezekowitz M. Connolly S.J. Xu L. Nakamya J. Conen D. Bangdiwala S.I. Yusuf S. Healey J.S. LVS‐HARMED Risk score for incident heart failure in patients with atrial fibrillation who present to the emergency department: data from a world‐wide registry. J. Am. Heart Assoc. 2021 10 18 e017735 10.1161/JAHA.120.017735 34514842
    [Google Scholar]
  57. Krisai P. Johnson L.S.B. Moschovitis G. Benz A. Ramasundarahettige C. McIntyre W.F. Wong J.A. Conen D. Sticherling C. Connolly S.J. Healey J.S. Incidence and predictors of heart failure in patients with atrial fibrillation. CJC Open 2021 3 12 1482 1489 10.1016/j.cjco.2021.07.016 34993460
    [Google Scholar]
  58. Shoemaker M.B. Muhammad R. Farrell M. Parvez B. White B.W. Streur M. Stubblefield T. Rytlewski J. Parvathaneni S. Nagarakanti R. Roden D.M. Saavedra P. Ellis C. Whalen S.P. Darbar D. Relation of morbid obesity and female gender to risk of procedural complications in patients undergoing atrial fibrillation ablation. Am. J. Cardiol. 2013 111 3 368 373 10.1016/j.amjcard.2012.10.013 23168290
    [Google Scholar]
  59. Kuck K.H. Brugada J. Fürnkranz A. Chun K.R.J. Metzner A. Ouyang F. Schlüter M. Elvan A. Braegelmann K.M. Kueffer F.J. Arentz T. Albenque J.P. Kühne M. Sticherling C. Tondo C. Impact of female sex on clinical outcomes in the fire and ice trial of catheter ablation for atrial fibrillation. Circ. Arrhythm. Electrophysiol. 2018 11 5 e006204 10.1161/CIRCEP.118.006204 29700058
    [Google Scholar]
  60. Huang W. Sun H. Luo Y. Tang Y. Xiong S. Long Y. Liu H. Including hemoglobin levels and female sex provide the additional predictive value of the APPLE score for atrial fibrillation recurrence post-catheter ablation. Hellenic J. Cardiol. 2023 Epub ahead of print. 10.1016/j.hjc.2023.12.003
    [Google Scholar]
  61. Conen D. Chae C.U. Glynn R.J. Tedrow U.B. Everett B.M. Buring J.E. Albert C.M. Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA 2011 305 20 2080 2087 10.1001/jama.2011.659 21610240
    [Google Scholar]
  62. Liu H. Wang K. Lin Y. Liang X. Zhao S. Li M. Chen M. Role of sST2 in predicting recurrence of atrial fibrillation after radiofrequency catheter ablation. Pacing Clin. Electrophysiol. 2020 43 11 1235 1241 10.1111/pace.14029 32735032
    [Google Scholar]
  63. Black-Maier E. Ren X. Steinberg B.A. Green C.L. Barnett A.S. Rosa N.S. Al-Khatib S.M. Atwater B.D. Daubert J.P. Frazier-Mills C. Grant A.O. Hegland D.D. Jackson K.P. Jackson L.R. Koontz J.I. Lewis R.K. Sun A.Y. Thomas K.L. Bahnson T.D. Piccini J.P. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction. Heart Rhythm 2018 15 5 651 657 10.1016/j.hrthm.2017.12.001 29222043
    [Google Scholar]
  64. Yamauchi R. Morishima I. Okumura K. Kanzaki Y. Morita Y. Takagi K. Nagai H. Watanabe N. Furui K. Yoshioka N. Miyazawa H. Shimojo K. Imaoka T. Sakamoto G. Murohara T. Catheter ablation for non-paroxysmal atrial fibrillation accompanied by heart failure with preserved ejection fraction: feasibility and benefits in functions and B-type natriuretic peptide. Europace 2021 23 8 1252 1261 10.1093/europace/euaa420 33693617
    [Google Scholar]
  65. Wong J.A. Conen D. Healey J.S. Johnson L.S.B. Modifiable risk factors predict incident atrial fibrillation and heart failure. Open Heart 2020 7 1 e001092 10.1136/openhrt‑2019‑001092 35594162
    [Google Scholar]
  66. Willems S. Borof K. Brandes A. Breithardt G. Camm A.J. Crijns H.J.G.M. Eckardt L. Gessler N. Goette A. Haegeli L.M. Heidbuchel H. Kautzner J. Ng G.A. Schnabel R.B. Suling A. Szumowski L. Themistoclakis S. Vardas P. van Gelder I.C. Wegscheider K. Kirchhof P. Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial. Eur. Heart J. 2022 43 12 1219 1230 10.1093/eurheartj/ehab593 34447995
    [Google Scholar]
  67. Rattka M. Pott A. Kühberger A. Weinmann K. Scharnbeck D. Stephan T. Baumhardt M. Bothner C. Iturbe Orbe M. Rottbauer W. Dahme T. Restoration of sinus rhythm by pulmonary vein isolation improves heart failure with preserved ejection fraction in atrial fibrillation patients. Europace 2020 22 9 1328 1336 10.1093/europace/euaa101 32449907
    [Google Scholar]
  68. Kirchhof P. Camm A.J. Goette A. Brandes A. Eckardt L. Elvan A. Fetsch T. van Gelder I.C. Haase D. Haegeli L.M. Hamann F. Heidbüchel H. Hindricks G. Kautzner J. Kuck K.H. Mont L. Ng G.A. Rekosz J. Schoen N. Schotten U. Suling A. Taggeselle J. Themistoclakis S. Vettorazzi E. Vardas P. Wegscheider K. Willems S. Crijns H.J.G.M. Breithardt G. Early rhythm-control therapy in patients with atrial fibrillation. N. Engl. J. Med. 2020 383 14 1305 1316 10.1056/NEJMoa2019422 32865375
    [Google Scholar]
  69. Anker S.D. Butler J. Filippatos G. Ferreira J.P. Bocchi E. Böhm M. Brunner-La Rocca H.P. Choi D.J. Chopra V. Chuquiure-Valenzuela E. Giannetti N. Gomez-Mesa J.E. Janssens S. Januzzi J.L. Gonzalez-Juanatey J.R. Merkely B. Nicholls S.J. Perrone S.V. Piña I.L. Ponikowski P. Senni M. Sim D. Spinar J. Squire I. Taddei S. Tsutsui H. Verma S. Vinereanu D. Zhang J. Carson P. Lam C.S.P. Marx N. Zeller C. Sattar N. Jamal W. Schnaidt S. Schnee J.M. Brueckmann M. Pocock S.J. Zannad F. Packer M. Empagliflozin in heart failure with a preserved ejection fraction. N. Engl. J. Med. 2021 385 16 1451 1461 10.1056/NEJMoa2107038 34449189
    [Google Scholar]
  70. Miyazaki D. Tarasawa K. Fushimi K. Fujimori K. Risk factors of readmission and the impact of outpatient management in heart failure patients: A national study in Japan. ESC Heart Fail. 2023 10 6 3299 3310 10.1002/ehf2.14498 37658614
    [Google Scholar]
  71. Inciardi R.M. Giugliano R.P. Park J.G. Nordio F. Ruff C.T. Chen C. Lanz H.J. Antman E.M. Braunwald E. Solomon S.D. Risks of heart failure, stroke, and bleeding in atrial fibrillation according to heart failure phenotypes. JACC Clin. Electrophysiol. 2023 9 4 569 580 10.1016/j.jacep.2022.11.032 37100536
    [Google Scholar]
/content/journals/ccr/10.2174/011573403X348844241129111639
Loading
Atrial Fibrillation Ablation in Heart Failure and Preserved Ejection Fraction: An Observational Study of Risk Factors for Heart Failure Hospitalization
Bentham Science Publishers ; https://doi.org/10.2174/011573403X348844241129111639
/content/journals/ccr/10.2174/011573403X348844241129111639
/content/journals/ccr/10.2174/011573403X348844241129111639
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: heart failure with preserved ejection fraction ; radiofrequency catheter ablation ; heart failure hospitalization ; Atrial fibrillation

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test